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protein	 translation	and	 lipid	biosynthesis.	Adaptation	 to	 iron	deficiency	 requires	
the	 global	 reorganization	 of	 cellular	 metabolism	 directed	 to	 optimize	 iron	
utilization.	 The	 budding	 yeast	Saccharomyces	 cerevisiae	 has	 been	widely	 used	 to	
characterize	the	responses	of	eukaryotic	microorganisms	to	iron	depletion.	In	this	
report,	 we	 used	 a	 genomic	 approach	 to	 investigate	 the	 contribution	 of	
transcription	 rates	 to	 the	modulation	of	mRNA	 levels	 during	 adaptation	of	 yeast	
cells	 to	 iron	 starvation.	 We	 reveal	 that	 a	 decrease	 in	 the	 activity	 of	 all	 RNA	
polymerases	 contributes	 to	 the	 down-regulation	 of	 many	 mRNAs,	 tRNAs	 and	
rRNAs.	 Opposite	 to	 the	 general	 expression	 pattern,	 many	 genes	 including	
components	 of	 the	 iron	 deficiency	 response,	 the	 mitochondrial	 retrograde	
pathway	 and	 the	 general	 stress	 response	 display	 a	 remarkable	 increase	 in	 both	
transcription	rates	and	mRNA	levels	upon	iron	limitation,	whereas	genes	encoding	
ribosomal	proteins	or	implicated	in	ribosome	biogenesis	exhibit	a	pronounced	fall.	
This	 expression	 profile	 is	 consistent	 with	 an	 irreversible	 activation	 of	 the	
environmental	stress	response.	The	phosphorylation	of	multiple	regulatory	factors	
strongly	 suggests	 that	 the	 conserved	 nutrient	 signaling	 pathway	 TORC1	 is	
inhibited	during	the	progress	of	iron	deficiency.	These	results	suggest	an	intricate	














Iron	 is	 a	 vital	 micronutrient	 for	 all	 forms	 of	 eukaryotic	 life	 because	 it	
participates	as	a	redox	cofactor	in	fundamental	cellular	processes.	Although	iron	is	
abundant,	 its	bioavailability	is	highly	restricted	under	aerobic	conditions	because	
of	 the	 insolubility	 of	 ferric	 iron	 at	 physiological	 pH.	 Thus,	 the	 acquisition	 and	
maintenance	of	sufficient	iron	levels	is	a	challenge	for	living	organisms,	which	have	
evolved	 sophisticated	 mechanisms	 to	 modulate	 iron	 homeostasis.	 Indeed,	 iron	
deficiency	 anemia	 is	 the	 most	 widespread	 nutritional	 disorder	 in	 humans,	
estimated	to	affect	more	than	two	billion	people	with	a	high	prevalence	in	children	
and	 women	 of	 childbearing	 age	 [1].	 Moreover,	 iron	 acquisition	 and	 regulation	
within	the	extremely	poor-iron	environment	of	the	host	is	crucial	for	the	progress	
of	 microbial	 infections	 [2-4].	 The	 budding	 yeast	 Saccharomyces	 cerevisiae	 has	
proved	 to	 be	 a	 reliable	 model	 to	 identify	 and	 characterize	 mechanisms	 of	
adaptation	 to	 iron	 deficiency.	 In	 response	 to	 iron	 scarcity,	 the	 Aft1	 and	 Aft2	





promotes	 the	 post-transcriptional	 degradation	 of	 multiple	 mRNAs	 within	 the	
electron	 transport	 chain	 and	 the	 tricarboxylic	 acid	 cycle,	 in	 order	 to	 limit	 iron	
consumption	in	mitochondrial	respiration	(reviewed	in	[5-8]).		
The	 conserved	 target	of	 rapamycin	 (TOR)	 serine/threonine	kinase	and	 its	
namesake	pathway,	which	were	first	discovered	in	yeast,	control	cell	growth	and	
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environmental	 conditions	are	 favorable,	 the	TORC1	pathway	promotes	 ribosome	
biogenesis	 and	 protein	 translation	 by	 favoring	 the	 expression	 of	 ribosomal	
proteins	 (RPs),	 ribosome	biogenesis	 (RiBi)	 factors,	 rRNAs	and	 tRNAs	at	multiple	
levels	[9].	Under	these	conditions,	TORC1	enhances	rRNA	expression	by	inhibiting	
the	proteasome-dependent	degradation	of	Rrn3,	 the	activating	 factor	of	 the	RNA	
polymerase	 I	 (RNA	 Pol	 I)	 [12],	 and	 tRNA	 transcription	 by	 regulating	 the	
phosphorylation	 stage	 of	 the	 RNA	 polymerase	 III	 (RNA	 Pol	 III)	 repressor	 Maf1.	
However,	 upon	 nutrient	 limitation,	 or	 in	 the	 presence	 of	 the	 lipophilic	 drug	
rapamycin,	the	inactivation	of	TORC1	provokes	a	decrease	in	the	phosphorylation	
of	 Sch9,	 and	 subsequently	 of	 Stb3	 and	 Dot6/Tod6	 transcription	 factors,	 which,	
together	with	the	Rpd3L	histone	deacetylase	complex,	repress	the	transcription	of	
RP	and	RiBi	genes	[9,	13].	Under	these	conditions,	Sfp1,	an	activator	of	RP	and	RiBi	
genes	 and	 a	 direct	 target	 of	 TORC1,	 is	 inactivated	 by	 dephosphorylation	 and	
exported	to	the	cytoplasm	(reviewed	in	[9]).		
The	mitochondrial	retrograde	(RTG)	response	 facilitates	the	production	of	
multiple	 biosynthetic	 intermediates.	 This	 signaling	 pathway	 communicates	
mitochondria	with	the	nucleus,	activating	the	expression	of	several	nuclear	genes	
that	are	necessary	for	the	synthesis	of	glutamate	and	other	anabolic	precursors	of	
amino	 acids	 through	 anaplerotic	 reactions.	 These	 genes	 include	 CIT2,	 the	
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peroxisomal	 isoform	 of	 citrate	 synthase	 that	 produces	 citrate	 as	 part	 of	 the	
glyoxylate	cycle,	and	the	genes	encoding	the	enzymes	of	the	three	first	steps	in	the	
tricarboxylic	acid	(TCA)	cycle:	CIT1,	coding	for	the	mitochondrial	isoform	of	citrate	
synthase;	 ACO1,	 aconitase,	 and	 IDH1/2,	 encoding	 NAD+-dependent	 isocitrate	
dehydrogenase	 (reviewed	 in	 [14]),	which	enable	cells	 to	maintain	glutamate	and	
glutamine	supplies	when	mitochondria	are	dysfunctional	and	cells	are	respiratory	
deficient	 through	 the	 synthesis	 of	 α-ketoglutarate.	 The	 retrograde	 signaling	
requires	 the	 nuclear	 translocation	 of	 a	 heterodimeric	 transcription	 factor	
constituted	 by	 Rtg1	 and	 Rtg3	 proteins,	 which	 occurs	 after	 the	 Rtg2-dependent	
partial	 dephosphorylation	 of	 Rtg3.	 The	 TORC1	 complex	 negatively	 regulates	
retrograde	 signaling	 through	 its	 component	 Lst8,	 acting	 both	 upstream	 and	
downstream	of	Rtg2	(reviewed	in	[14,	15]).	
Previous	genome-wide	 studies	have	analyzed	 the	 changes	 in	mRNA	 levels	
that	S.	cerevisiae	undergoes	in	response	to	iron	deficiency	[16-18].	The	information	
obtained	 from	 these	 global	 studies	 is	 nonetheless	 limited,	 as	 it	 involves	 the	
measurement	of	 steady-state	mRNA	amounts	 (RA).	To	assess	 the	contribution	of	
transcription	to	the	adaptation	to	iron	limitation,	we	have	used	the	genomic	run-
on	 (GRO)	 technique	 [19]	 to	 determine	 the	 transcription	 rate	 (TR)	 for	 the	 entire	
yeast	transcriptome	during	the	progress	from	mild	to	severe	iron	deficiency.	Our	
data	 uncover	 new	 insights	 onto	 the	 molecular	 mechanisms	 involved	 in	 the	
adaptation	to	iron	deprivation,	including	the	activation	of	the	environmental	stress	
response	(ESR)	and	the	mitochondrial	retrograde	response,	and	a	decrease	in	the	





2.1.	Yeast	 strains,	plasmids	and	growth	 conditions.	The	yeast	 strains	used	 in	
this	study	are	listed	in	Table	S1.	The	pCM64-PACO1-lacZ	reporter	plasmid	was	made	
by	 the	 insertion	 of	 a	 613-bp	 PCR	 amplified	 fragment	 from	 the	 ACO1	 promoter	
region	 into	 the	 BglII-BamHI	 sites	 of	 pCM64	 vector	 (from	 Charles	 Moehle).	 The	
Sfp1-GFP	 plasmid	was	 constructed	 by	 amplifying	 SFP1	 sequence	 flanked	 by	 SalI	
and	SmaI	restriction	sites,	digestion	and	cloned	into	pUG35	plasmid.	Yeast	W303	
cells	were	cultivated	in	600	mL	of	SC	medium	for	at	least	15	hours	to	reach	early	
exponential	 phase	 (OD600	 =	 0.2).	 Then,	 100	 μM	 of	 the	 Fe2+-specific	 chelator	
bathophenanthroline	 disulfonic	 acid	 (BPS;	 Sigma)	 was	 added,	 and	 different	
aliquots	were	isolated	at	0,	10,	30,	90,	180	and	360	minutes	after	iron	limitation.	In	
the	 case	 of	 yeast	 cells	 from	 the	 BY4741	 or	 other	 backgrounds,	 3	 mL	 overnight	
precultures	were	used	to	inoculate	50	mL	of	SC	(+Fe)	or	SC	+	100	μM	BPS	cultures	




were	 grown	 for	 8	 hours	 in	 continuous	 shaking.	 Samples	 were	 taken	 for	
observation	in	an	Olympus	Bx51	fluorescence	microscope.	
2.2.	Determination	and	analyses	of	 transcription	rates	and	mRNA	levels.	To	
determine	 the	TR	and	RA	of	each	gene	on	a	genome-wide	scale,	we	 followed	 the	
GRO	 and	 mRNA	 measurement	 protocols	 previously	 described	 [19],	 except	 that	
cells	 were	 frozen	 after	 collection	 and	 the	 reverse	 transcription	 of	 mRNA	 was	
	 9	
carried	 out	 using	 an	 oligo-d(T)15VN	 (V	means	A,	 G,	 or	 C;	N	means	A,	 G,	 C,	 or	 T)	
instead	 of	 random	 primers.	 Three	 biologically	 independent	 replicates	 were	
performed	for	each	experiment.	Quantification	and	normalization	of	the	data	were	
performed	as	reported	[19].	Changes	 in	 the	normalized	median	values	of	TR	and	
RA	 were	 evaluated	 by	 cluster	 analysis	 with	 WebMeV	 (Multiple	 Experiment	
Viewer)	 web	 server	 (http:/mev.tm4.org).	 To	 determine	 cluster	 composition,	 we	
used	a	k-means	clustering	with	k=10	and	Euclidean	distance.	After	obtaining	 the	
heatmap,	 the	color	code	was	used	to	visually	select	 the	gene	clusters.	Finally,	we	
used	 the	Gene	Ontology	enRIchment	anaLysis	and	visuaLizAtion	 tool	 (http://cbl-
gorilla.cs.technion.ac.il)	to	ascertain	the	statistical	significance	of	the	enrichment	of	
clusters	 in	 specific	 gene	 ontology	 (GO)	 categories.	 We	 determined	 adjusted	 p-
values	with	FDR	multiple	correction.	
2.3.	 Total	 poly(A)	 RNA	 measurements.	 We	 used	 a	 dot-blot	 procedure	 to	
determine	the	poly(A)	mRNA/cell	as	previously	described	[19].	
2.4.	 RNA	 analyses.	 Total	 yeast	 RNA	 isolation,	 reverse	 transcription	 and	
quantitative	PCR	(RT-qPCR)	were	performed	as	previously	described	[20].	Specific	
primer	pairs	were	used	for	the	qPCR	(listed	in	Table	S2).	The	data	and	error	bars	
represent	 the	 relative	 average	 and	 standard	 deviations	 of	 three	 independent	
biological	samples.	
2.5.	 Protein	 analyses.	Yeast	 proteins	 were	 extracted	 and	 analyzed	 by	Western	
blot	 as	 previously	 reported	 [20],	 except	 in	 the	 case	 of	 Sch9	 and	 Maf1	 protein	
phosphorylations,	 which	 were	 studied	 with	 specific	 procedures	 [21-23].	 Since	
Sch9	protein	is	around	100	KDa,	a	chemical	fragmentation	of	Sch9-HA	protein	was	
performed	 with	 NTCB	 (2-nitro-5-thiocyanatobenzoic	 acid),	 which	 cyanylates	
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cysteine	residues	that	under	alkaline	conditions	are	followed	by	chain	cleavage	at	
the	 modified	 residues.	 Chromatin	 immunoprecipitation	 (ChIP)	 assays	 were	
performed	to	determine	RNA	Pol	 II	binding	to	Rtg1-regulated	gene	promoters	as	
described	[24].	Cell	extracts	for	ChIP	were	incubated	with	Dynabeads	Pan	Mouse	




(1:20,000	 dilution;	 clone	 8WG16,	 Covance),	 anti-Rpb1-Ser2-Phosphorylated	
(1:20,000	dilution;	Abcam),	anti-HA	(1:5,000	dilution;	3F10,	Sigma),	anti-Rpa190A	
(1:20,000	 dilution;	 from	 Olga	 Calvo),	 anti-GFP	 (1:10,000	 dilution;	 Roche),	 anti-
Rps6	 (1:1,000	 dilution;	 Cell	 Signaling	 Technology),	 anti-Rps6-Ser235/Ser236	
(1:1,000	 dilution;	 Cell	 Signaling	 Technology),	 anti-Maf1	 (1:10,000	 dilution;	 from	
Olivier	 Lefebvre)	 and	 anti-Pgk1	 (1:10,000	 dilution;	 22C5D8,	 Invitrogen).	
Immunoblot	 images	 were	 obtained	 with	 an	 ImageQuant	 LAS	 4000	 mini	
Biomolecular	 Imager	 (GE	 Healthcare	 Life	 Sciences),	 and	 protein	 levels	 were	
quantified	with	ImageQuant	TL	analysis	software	(GE	Healthcare	Life	Sciences).	
2.6.	Determination	of	glucose	and	ethanol	concentrations.	Glucose	and	ethanol	
concentrations	 in	 all	 the	 supernatant	 samples	 were	 determined	 by	 HPLC	 in	 a	
Surveyor	Plus	Chromatograph	(Thermo	Fisher	Scientific,	Waltham,	MA)	equipped	
with	a	 refraction	 index	detector,	 an	autosampler	and	a	UV-Visible	detector.	Each	
sample	was	analyzed	in	duplicate.	
2.7.	Miscellaneous.	Cell	median	volumes	were	determined	with	a	Coulter	Counter	
Z	 (Beckman	 Coulter,	 USA).	 Rrp12-GFP,	 Sfp-GFP	 and	 Rtg1-GFP	 expressing	 cells	
were	 stained	 with	 4’,6-diamidino-2-phenylindole	 (DAPI)	 and	 visualized	 in	 an	
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Axioskop	 2	 fluorescence	 microscope	 (Zeiss),	 and	 images	 were	 captured	 with	 a	
SPOT	camera	(Diagnostic	Instruments).	β-Galactosidase	activity	was	measured	as	
previously	 described	 [24].	 Total	 intracellular	 iron	 levels	 were	 determined	 as	










	 Various	 studies	 have	 shown	 that	 the	 yeast	 S.	 cerevisiae	 alters	 the	 steady-
state	 levels	 of	 many	 transcripts	 in	 response	 to	 nutritional	 or	 genetic	 iron	
deficiencies	 [16-18].	 However,	 little	 is	 known	 about	 the	 relative	 contribution	 of	
transcription	 to	 the	abundance	of	 specific	mRNAs	upon	 iron	scarcity.	To	address	
this	question,	we	determined	the	TR	and	the	RA	per	cell	of	the	entire	yeast	genome	
during	the	progress	of	 iron	deficiency.	We	cultivated	a	haploid	prototroph	W303	
yeast	 strain	 to	early	exponential	phase	 (A600	=	0.3;	7·106	 cells/mL),	 and	 then	we	
added	 100	 µM	 of	 bathophenanthroline	 disulfonate	 (BPS),	 a	 widely	 used	 Fe2+-
specific	 chelator	 that	 limits	 extracellular	 iron	 bioavailability.	 With	 the	 aim	 of	
deciphering	 both	 early	 and	 late	 responses	 to	 iron	 deprivation,	 aliquots	 were	
collected	up	to	six	hours	after	iron	limitation.	Growth	rate	slightly	decreased	after	
6	 hours	 of	 iron	 depletion,	 but	 cells	 continued	 duplicating	 up	 to	 24	 hours	 under	
these	 conditions	 (Figure	 S1A	 and	 S1B).	 Metabolite	 analyses	 showed	 a	 mild	
decrease	in	glucose	concentration	and	increase	in	ethanol	levels	(Figure	S1C).	No	
important	 changes	were	 observed	 in	 cellular	 volume	 during	 the	 progress	 of	 the	
experiment	(Figure	S1D).	Intracellular	iron	levels	displayed	a	14%	decrease	in	the	
initial	30	minutes,	and	further	diminished	along	the	progress	of	the	iron	depletion	
(Figure	 S1E).	 To	 quantify	 the	 RNA	 polymerase	 II	 (RNA	 Pol	 II)	 TR	 of	 each	 yeast	
gene,	we	used	the	GRO	method	[19]	(Materials	and	Methods).	The	whole	RNA	Pol	
II	 TR	 was	 obtained	 from	 the	 median	 of	 the	 TR	 corresponding	 to	 all	 the	 yeast	
protein-coding	genes,	whereas	the	total	RA	was	determined	by	hybridization	with	
labeled	 oligo(dT)	 [19]	 (Materials	 and	 Methods).	 The	 profile	 of	 total	 RA	 and	 TR	
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distinguished	 three	 different	 stages	 along	 the	 iron	 deficiency	 (Figure	 1A).	 First,	
cells	experienced	an	early	response	to	low	iron	(from	0	to	30	min),	in	which	both	
total	RA	and	TR	decreased.	Following	this	initial	stage,	the	TR	and	RA	increased	to	





decreased	 as	 the	 iron	 deficiency	 advanced	 (Figure	 1B	 and	 1C).	 Remarkably,	 the	
levels	of	elongating	Rpb1,	which	is	transiently	phosphorylated	at	the	second	serine	
of	 the	 heptapeptide	 repeat	 within	 its	 carboxy-terminal	 domain	 (Rpb1-S2-P),	
further	diminished	(Figure	1C),	indicating	a	stronger	defect	in	elongating	RNA	Pol	




Figure 1. Changes in RNA polymerase II during the progress of iron deficiency. 
(A) RNA Pol II transcription rate (TR) and total poly(A) mRNA (RA) per cell. At time 
zero, 100 µM BPS was added to W303 cells exponentially growing in SC at 30°C. 
Aliquots were processed to measure total RA per cell and RNA Pol II TR per cell at the 
indicated times, (Materials and Methods). The values were referred to their respective 
values at time zero. The standard deviation of at least three biologically independent 
replicates is shown. (B) RPB1 mRNA levels were determined by RT-qPCR using 
specific primers. Average values and standard deviations from at least two independent 
experiments are shown and referred to those in time zero. (C) The levels of total and 
elongating RNA pol II (Rpb1 and Rpb1-S2-P, respectively) were determined by 
Western blot analyses using the anti-Rpb1 antibody that recognizes all the RNA pol II 
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pol II. A representative experiment of three independent biological replicates is shown. 






profiles	 (Supplementary	Data	S1).	The	 individual	RA	values	after	6	hours	of	 iron	
deficiency	were	not	included	in	these	analyses	because	we	obtained	no	detectable	
signal.	By	 this	method,	we	classified	4421	genes	 into	10	different	clusters,	which	
were	 statistically	 enriched	 in	 specific	 gene	 ontology	 (GO)	 functional	 categories	
(Figure	2;	Supplementary	Data	S2;	only	representative	GO	categories	with	p	≤	10-4	
are	indicated).	The	profile	for	each	cluster	was	represented	(Figure	3).	Consistent	
with	 the	activation	of	 the	 iron	regulon	by	 the	Aft1	and	Aft2	 transcription	 factors	




iron	 deprivation	 (Supplementary	 Data	 S2).	 Cluster	 4	 also	 contained	 the	 Mga2-
dependent	transcriptional	induction	reported	for	the	OLE1	fatty	acid	desaturase	in	
response	to	iron	limitation	[24].	Interestingly,	cluster	2	contained	genes	whose	RA	
decrease	 was	 more	 pronounced	 than	 its	 drop	 in	 TR,	 suggesting	 a	 significant	
contribution	of	mRNA	decay	 to	 its	 regulation	 (Figure	3).	 In	 fact,	 the	GO	category	
“respiratory	 electron	 transport	 chain”	 contains	 multiple	 targets	 of	 the	 iron-
regulated	 Cth2	 mRNA	 decay	 factor	 (Supplementary	 Data	 S2).	 All	 these	 results	
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validated	 our	 experimental	 conditions	 and,	 from	 here	 onwards,	 we	 focused	 on	
identifying	 new	 functional	 categories	 coordinately	 regulated	 in	 response	 to	 iron	
depletion.	Cluster	4,,	which	exhibited	an	increase	in	both	TR	and	RA,	was	enriched	
in	the	GO	category	“cellular	response	to	external	stimulus”	(p	=	3.9·10-8)	(Figures	2	
and	 3).	 Cluster	 5,	 over-represented	 in	 the	 GO	 functional	 categories	 “oxidation-
reduction	process”	 and	 “small	molecule	metabolic	process”	 (p	 =	6.6·10-8	 and	p	 =	
2.5·10-5,	 respectively),	 displayed	 identical	 TR	 and	RA	patterns	with	 only	 a	 slight	
and	transient	decrease	at	30	min	of	iron	depletion	(Figure	3),	In	addition	to	cluster	
2,	clusters	6	to	10	showed	an	overall	decrease	in	TR	(Figure	3).	A	similar	pattern	
for	 both	 TR	 and	 RA	 was	 observed	 in	 cluster	 7,	 with	 three	 significative	 GO	
categories	 “organonitrogen	 compound	 biosynthetic	 process”,	 “translation”	 and	
“mitochondrial	 translation”	 (p	 =	 7.6·10-10,	 p	 =	 1.2·10-7	 and	 p	 =	 2.8·10-5	
respectively).	 Representative	 GO	 categories	 were	 also	 identified	 in	 cluster	 8	
(“nucleic	acid	metabolic	process”,	p	=	6.8·10-9;	and	“cell	cycle	process”,	p	=	7.9·10-9)	
and	cluster	9	(“endosomal	 transport”,	p	=	6.8·10-9;	and	“protein	 localization”,	p	=	
8.6·10-6)	 (Figures	 2).	 Finally,	 cluster	 10	 contained	 two	 representative	 GO	
functional	 categories:	 “RNA	 metabolic	 process”	 (p	 =	 8.6·10-6),	 and	 “ribosome	
biogenesis”	(p	=	7.6·10-39).	Remarkably,	the	p-value	for	“ribosome	biogenesis”	was	
even	 lower	 than	 the	p-value	 obtained	 for	 the	 “iron	 ion	homeostasis”	 category	 in	





Figure 2. Clustering of genes according to their TR and RA profiles. Time course 
profiles for both parameters were considered for clustering. Dataset series are referred 
to their respective time zero in logarithm scale. Relative repression is shown in green 
and relative induction in red. The most significant GO categories (p value ≤ 10-4) are 
indicated with their respective p values. The individual data for each gene and the list of 




Figure 3. Global changes in TR and RA during the progress in iron deficiency 
corresponding to each cluster. The graphs represent the median TR and RA for all 
genes included in each group. The values are referred to time zero. Clusters are defined 
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expression	program	called	 the	environmental	 stress	 response	 (ESR)	 to	acclimate	
to	multiple	 suboptimal	 conditions	 [26-28].	 The	ESR	 set	 of	 genes	 is	 comprised	of	
∼300	induced	mRNAs	(iESR),	which	encompass	genes	involved	in	protecting	cells	
against	 stress	 conditions,	 and	 ∼600	 repressed	 transcripts	 (rESR)	 encoding	 RPs,	
RiBis	and	other	proteins	implicated	in	translation	[26].	Since	a	notable	conclusion	
of	 our	 clustering	 was	 the	 down-regulation	 of	 genes	 involved	 in	 ribosome	
biogenesis	 and	 translation	 (p	 <	 10-13),	 we	 decided	 to	 explore	 whether	 the	 ESR	
program	 was	 initiated	 in	 response	 to	 iron	 depletion.	 For	 this	 purpose,	 we	
represented	the	median	TR	and	RA	profiles	of	the	iESR	and	rESR	genes	referred	to	
a	 normalized	 global	 TR	 and	RA	 pattern,	 respectively,	 during	 the	 progress	 of	 the	
iron	limitation.	Consistent	with	an	activation	of	the	ESR	program,	we	observed	an	
up-regulation	of	the	iESR	and	a	down-regulation	of	the	rESR	set	of	genes	for	both	
the	 TR	 and	 RA	 profiles	 in	 response	 to	 iron	 deficiency	 (Figure	 4A).	 This	 result	





commonly	observed	 in	 response	 to	oxidative	 and	other	 stresses	 (Figure	4A,	ESR	
RA-ox)[26,	 28].	 Previous	 studies	 had	 demonstrated	 that	 the	 general	 stress	
transcription	 factors	Msn2	 and	Msn4	 contribute	 to	 the	 activation	 of	 a	 set	 of	 the	
iESR	 genes	 in	 response	 to	 various	 stresses	 [26].	 To	 ascertain	 the	 potential	
relevance	of	the	iESR	signature	and	the	Msn2	and	Msn4	transcription	factors	to	the	
adaptation	 to	 iron	 depletion,	 we	 assayed	 the	 growth	 of	 an	msn2Δmsn4Δ	 yeast	
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mutant	in	iron-deficient	conditions	and	observed	a	significant	decrease	in	growth	
as	 compared	 to	wild-type	 cells	 (Figure	 4B).	 These	 results	 support	 a	 role	 for	 the	
Msn2	and	Msn4	 transcription	 factors	and	 the	 iESR	genes	 in	 the	 response	 to	 iron	
deficiency.	
	
Figure 4. Activation of the ESR in response to iron depletion. (A) The median TR 
and RA corresponding to the genes classified as iESR and rESR was represented during 
the progress of the iron deficiency and referred to the normalized global patterns of TR 
and RA, respectively. The median RA pattern of the iESR and rESR genes in response 
to the oxidative stress achieved by addition of 0.1 mM ter-butyl hydroperoxide 
previously reported [29] is also represented as ESR-ox (circles). (B) Msn2 and Msn4 
transcription factors are required for growth in iron-deficient conditions. Wild-type 
BY4741 and msn2Δmsn4Δ double mutant were grown in SC (+Fe) and SC with 600 
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We	 noticed	 that	 the	 median	 TR	 of	 genes	 included	 in	 cluster	 10,	 and	
specifically	 the	RiBi	 and	RP	 genes,	 decreased	when	 the	 iron	deficiency	persisted	
(Figure	 3;	 Supplementary	 Data	 S2).	 To	 verify	 that	 this	 drop	 in	 TR	 had	 a	





that,	 in	 response	 to	 stress	 or	 low	 nutrient	 availability,	 exits	 the	 nucleus,	 and	
consequently	RP	and	RiBi	expression	decreases	(reviewed	in	[9]).	We	investigated	
Sfp1	subcellular	localization	under	both	iron-sufficient	and	deficient	conditions.	As	
expected,	 Sfp1	 localized	 to	 the	 nucleus	 under	 iron-replete	 conditions	 (Figure	 5C	
and	 5D,	 left).	 Consistent	 with	 a	 decrease	 in	 RP	 and	 RiBi	 gene	 expression,	 Sfp1	
exited	the	nucleus	when	iron	was	depleted	(Figure	5C	and	5D,	right).	These	results	
demonstrate	that	Sfp1	subcellular	localization	responds	to	iron	bioavailability,	and	
probably	 alters	RP	 and	RiBi	 gene	 expression.	Another	mechanism	 that	 regulates	
RP	 and	 RiBi	 gene	 expression	 involves	 Stb3	 and	 the	 paralog	 proteins	 Dot6	 and	
Tod6,	 which	 recruit	 the	 RPD3L	 histone	 deacetylase	 complex	 to	 RP	 and	 RiBi	
promoters	to	repress	transcription	when	growth	conditions	are	not	favorable	[13].	





RiBi	 RA	 down-regulation	 caused	 by	 iron	 depletion	 was	 disrupted	 in	 the	
dot6Δtod6Δ	 and	 rpd3Δ	 mutants	 (Figure	 5F).	 These	 results	 strongly	 suggest	 that	





Figure 5. Regulation of Sfp1, Sch9, Dot6, Stb3, Rpd3, RP and RiBi genes in 
response to iron deficiency. (A, B) Determination of specific RP and RiBi mRNA 
levels during the progress of iron deficiency by RT-qPCR. W303 cells were grown as 
indicated in Figure 1A (GRO experiment). ACT1 mRNA levels were used to normalize. 
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shown and referred to time zero. (C, D) Sfp1 relocalizes to the cytoplasm in response to 
iron deficiency. Wild type yeast cells transformed with the SFP1-GFP plasmid were 
grown at 30 °C in SD (+Fe) and SD with 100 µM BPS (-Fe) for 8 hours. Sfp1-GFP 
subcellular localization was determined by fluorescence microscopy. DAPI was used as 
a marker for the nucleus. A merge between GFP and DAPI is shown. Representative 
images are shown (panel C). The white bar represents 10 µm. The percentage of cells 
with either predominantly cytoplasmic or nuclear GFP signal was determined by 
triplicate. The average and the standard deviation are represented (Panel D). Similar 
results were obtained in SC. (E, F) Fold change in RP and RiBi mRNA levels. Wild 
type BY4741, dot6Δtod6Δ, stb3Δ y rpd3Δ yeast strains were grown at 30 °C in SC 
(+Fe) and SC with 100 µM BPS (-Fe) for 9 hours. Specific mRNA levels of RP and 
RiBi genes were determined as mentioned above. Mean values of fold induction in iron 
deficiency and standard deviations from at least two independent experiments are 
shown. (G) Dot6 protein levels. Yeast cells expressing DOT6-HA were grown at 30 °C 
in SC (+Fe) and SC with 100 µM BPS (-Fe) for 9 hours. Dot6-HA and Pgk1 protein 
levels were analyzed by western blot with anti-HA and anti-Pgk1 antibodies, 
respectively. Protein levels have been quantified and the Dot6-HA/Pgk1 ratio indicated. 
(H) Determination of Sch9 protein levels and phosphorylation state. Yeast cells 
expressing SCH9-HA were grown as in panel E and NTCB-treated protein extracts were 
analyzed as described in Materials and methods. (I) Determination of Rps6 protein 
levels and phosphorylation state. W303 cells were grown as described in Figure 1A. 
The levels of total Rps6 and phosphorylated Rps6 (Rps6-P) protein were determined by 
Western blot analyses using the anti-Rps6 and anti-Rps6-Ser235/236 antibodies, 
respectively. Protein levels have been quantified and the Rps6-P/Rps6 ratio indicated. A 
representative experiment of three independent biological replicates is shown. 
	
	 Under	 optimal	 growth	 conditions,	 the	 TORC1	 kinase	 complex	 directly	
phosphorylates	 and	 activates	 Sch9	 kinase	 (reviewed	 in	 [9]).	 Then,	 Sch9	
phosphorylates	 Stb3	 and	 Dot6-Tod6	 proteins,	 inhibiting	 their	 function	 and	
facilitating	 the	 transcription	 of	 RP	 and	 RiBi	 genes	 [13].	 Upon	 TORC1	 inhibition,	
Sch9	is	dephosphorylated	and	deactivated,	and	accordingly	the	downstream	Stb3	
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and	 Dot6-Tod6	 proteins	 are	 also	 dephosphorylated	 and	 become	 active	 in	 the	
repression	 of	 RP	 and	 RiBi	 genes.	 The	 Stb3	 and	 Dot6-Tod6	 dependent	 down-
regulation	 of	 RP	 and	 RiBi	 genes	 promoted	 by	 the	 depletion	 of	 iron	 predicted	 a	
dephosphorylation	 of	 these	 regulatory	 factors.	 We	 first	 observed	 that	 iron	
deficiency	 promoted	 a	 decrease	 in	 Dot6	 protein	 abundance,	 although	 no	
convincing	conclusions	could	be	established	on	Dot6	phosphorylation	state	(Figure	
5G	 and	 Figure	 S2C).	 Then,	 we	 determined	 the	 phosphorylation	 state	 of	 the	 key	
TORC1-dependent	 kinase	 Sch9.	 We	 observed	 that	 Sch9	 protein	 was	 gradually	
dephosphorylated	 and	 its	 abundance	 diminished	 during	 the	 advance	 of	 the	 iron	
deficiency	to	reach	a	stage	similar	to	that	obtained	with	the	rapamycin	treatment	
(Figure	 5H,	 Figure	 S2D	 and	 S2E).	 Collectively,	 these	 results	 suggest	 that	 the	
dephosphorylation	of	 the	TORC1-dependent	kinase	Sch9	 limits	 the	expression	of	
RP	and	RiBi	genes	in	response	to	iron	starvation	via	Stb3,	Dot6-Tod6	and	Rpd3.	
In	 addition	 to	 the	 regulation	 of	 RP	 and	 RiBi	 gene	 transcription,	 the	
inhibition	 of	 the	 TORC1	 cascade	 promotes	 a	 decrease	 in	 the	 levels	 of	 newly	
synthesized	 ribosomal	 subunits	 that	 causes	 the	 nucleolar	 entrapment	 of	 specific	
ribosomal	biogenesis	factors	[30].	To	address	if	this	was	the	case	of	iron	deficiency,	
we	 determined	 the	 subcellular	 localization	 of	 the	 Rrp12-GFP	 protein,	 which	 is	
trapped	in	the	nucleolus	upon	TOR	inactivation	[30].	We	observed	that	the	Rrp12-
GFP	protein	did	not	properly	distribute	all	over	the	cell	when	iron	was	scarce,	but	
instead	 it	 was	 trapped	 in	 the	 nucleus	 (Figure	 S3).	 We	 also	 determined	 the	
phosphorylation	 state	 of	 the	 small	 ribosomal	 subunit	 Rps6,	 which	 is	
phosphorylated	 by	 the	 Ypk3	 kinase	 in	 a	 TORC1-dependent	manner	 [31,	 32].	 By	
using	an	antibody	 specific	 for	 its	phosphorylated	 form,	we	 could	 state	 that	Rps6	
dephosphorylates	upon	iron	depletion,	whereas	no	changes	were	observed	for	the	
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levels	 of	 total	 Rps6	 protein	 (Figure	 5I).	 Both	 Rrp12	 mislocalization	 and	 Rps6	




The	 TORC1	 pathway	 coordinates	 the	 expression	 of	 RP	 and	 RiBi	 genes	 to	
rRNA	 and	 tRNA	 synthesis	 in	 response	 to	 different	 environmental	 conditions.	
Specifically,	TORC1	regulates	the	activity	of	RNA	Pol	I,	which	is	responsible	for	the	
transcription	of	the	35S	precursor	of	the	mature	25S,	18S	and	5.8S	rRNAs,	and	RNA	
Pol	 III,	which	 transcribes	 tRNA	 genes	 and	 the	 5S	 rRNA,	 at	 different	 steps	 in	 the	
transcription	 cycle	 (reviewed	 in	 [9]).	 Therefore,	 we	 explored	 whether	 the	
deprivation	of	 iron	altered	 the	synthesis	of	 rRNA.	We	 first	observed	 that	 the	RA,	
which	mostly	corresponds	to	rRNA	(∼80%),	was	fairly	constant	up	to	three	hours	
of	iron	deficiency,	but	lowered	to	50%	after	6	hours	(Figure	6A).	Consistent	with	a	




A190	 (Rpa190),	 strongly	 diminished	 after	 6	 hours	 of	 iron	 deficiency,	 when	 the	








Figure 6. The activities of RNA polymerase I and III are inhibited in iron scarcity. 
(A) Total RNA per cell during the iron deficiency kinetics. W303 cells were grown as 
in Figure 1A and total RNA per cell determined. (B) The RNA Pol I transcription rate 
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of the GRO experiment. (C) The 18S and 25S RNA levels were analyzed by RT-qPCR 
using specific primers. ACT1 was used to normalize. (D) The protein levels of the 
largest RNA Pol I subunit Rpa190 and Pgk1 were determined by Western Blot using the 
anti-Rpa190 and anti-Pgk1 antibodies, respectively. (E) Determination of Rrn3 protein 
levels. Yeast cells expressing RRN3-GFP were grown at 30 °C in SC (+Fe) and SC with 
100 µM BPS (-Fe) for 9 hours. Rrn3-GFP and Pgk1 protein levels were analyzed with 
anti-GFP and anti-Pgk1 antibodies, respectively. (F) Yeast cells expressing HA epitope-
tagged RPC160 were grown at 30 °C in SC (+Fe), SC with 100 µM BPS (-Fe) for 11 
hours and in presence of rapamycin (200 ng/ml) for 30 minutes. Rpc160-HA, Maf1 and 
Pgk1 protein levels were analyzed by Western blot with anti-HA, anti-Maf1 and anti-
Pgk1 antibodies, respectively. Rpa190, Rrn3-GFP, Maf1, RPC160-HA, and Pgk1 
protein levels have been quantified, and the Rpa190/Pgk1, Rrn3/Pgk1, Rpc160-
HA/Pgk1 and Maf1-P (phosphorylated)/Maf1 ratio indicated. (G) Determination of 
specific tRNA levels. The level of some tRNAs was determined in the same conditions 




protein	Maf1.	Under	 conditions	 favorable	 for	 growth,	 Sch9	phosphorylates	Maf1,	
leading	to	its	retention	in	the	cytoplasm.	On	the	contrary,	TORC1	inactivation	leads	
to	 the	 dephosphorylation	 of	 Maf1	 and	 its	 accumulation	 in	 the	 nucleus	 where	 it	
binds	to	the	RNA	Pol	III	blocking	tRNA	synthesis	[22].	To	investigate	whether	this	
branch	of	the	TORC1	pathway	was	also	altered	by	changes	in	iron	availability,	we	
determined	 the	 electrophoretic	 mobility	 of	 Maf1	 protein	 under	 iron-deficient	
conditions,	 which	 is	 an	 indicative	 of	 its	 phosphorylation	 state.	 Similarly	 to	 the	





low	 iron	 levels	 (Figure	 6F).	 Consistent	 with	 defects	 in	 RNA	 Pol	 III	 activity,	 the	
levels	 of	multiple	 tRNAs	 decreased	 in	 iron-deficient	 conditions	 (Figure	 6G).	 The	
decrease	in	total	and	elongating	RNA	Pol	II	shown	above	(Figure	1C)	matches	with	
the	pattern	 exhibited	by	 the	other	 two	RNA	Pol	 (Figure	6D	and	6F).	Thus,	 these	
results	 strongly	 suggest	 that	 the	 activity	 of	 all	 RNA	 polymerases	 decreases	 in	




The	 Lst8	 integral	 component	 of	 the	 TORC1	 kinase	 complex	 negatively	
regulates	 the	mitochondrial	RTG	pathway.	Therefore,	 TORC1	 inhibition	 activates	
the	RTG	signaling.	To	address	whether	this	was	the	case	in	iron	deficiency,	we	paid	
attention	to	the	TR	of	the	RTG	genes	IDH1,	IDH2,	and	CIT2	,	which	were	included	in	
the	 TR+RA	 cluster	 4.	 Remarkably,	 the	 TR	 of	 all	 RTG	 genes	 augmented	 at	 severe	
iron	depletion	 (Figure	7A).	 This	TR	up-regulation	 correlated	with	 an	 increase	 in	
mRNA	 levels,	 except	 for	 the	 ACO1	 transcript	 (Figure	 7B).	 Previous	 studies	 had	
shown	 that,	 in	 response	 to	 iron	 depletion,	 the	mRNA-binding	 proteins	 Cth1	 and	
Cth2	 promote	 the	 degradation	 of	 multiple	 mRNAs	 including	 ACO1	 [16,	 33].	
Consistent	with	 a	 simultaneous	post-transcriptional	 decay	by	Cth1	 and	Cth2,	we	
observed	 an	 increase	 in	 ACO1	 mRNA	 levels	 in	 iron-deficient	 cth1Δcth2Δ	 cells	
(Figure	S5A).	The	Rtg1-Rtg3	transcription	factors	and	the	Rtg2	regulatory	protein	
activate	 the	RTG	pathway	 in	 response	 to	mitochondrial	 defects	 [14,	 15].	Various	
observations	 indicated	that	they	were	also	required	for	the	activation	of	the	RTG	
pathway	when	 iron	was	scarce.	First,	no	up-regulation	 in	 the	mRNA	levels	of	 the	
	 30	
different	RTG	 genes	was	 observed	 in	 iron-deficient	 rtg1Δ,	 rtg2Δ	 and	 rtg3Δ	 cells	
(Figure	7C).	Second,	a	fusion	of	the	ACO1	promoter	to	lacZ	caused	an	increase	in	β-
galactosidase	activity	when	iron	was	depleted,	which	did	not	occur	in	rtg1Δ,	rtg2Δ	
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Figure 7. The retrograde pathway is transcriptionally activated upon iron 
depletion. (A) Transcription rates of RTG genes during the response to iron deficiency 
obtained from the GRO experiment. (B) Fold induction of RTG mRNA levels in 
response to low iron. W303 cells were grown as described in Figure 1A, and RNA 
extracted and analyzed at six hours of iron deficiency by RT-qPCR using specific 
primers. (C) Wild type BY4741, rtg1Δ, rtg2Δ and rtg3Δ strains were grown at 30 °C in 
SC (+Fe) and SC with 100 µM BPS (-Fe) for 9 hours. The mRNA levels of specific 
RTG genes were determined by RT-qPCR using specific primers. ACT1 was used as a 
loading control. Mean values of fold induction in iron deficiency and standard 
deviations from at least two independent experiments are shown. (D) RNA Pol II 
chromatin immunoprecipitation. The wild-type BY4741 and rtg1Δ cells were grown as 
described in panel B. Proteins were extracted and immunoprecipitated with anti-RNA 
Pol II monoclonal antibody. DNA was extracted and binding to RTG promoter regions 
was determined by RT-qPCR. The results were normalized to FUS1 promoter. Mean 
values of fold induction in iron deficiency and standard deviations from at least two 
independent experiments are shown. (E, F) Rtg1 moves to the nucleus in response to 
iron deficiency. Wild type yeast cells transformed with the RTG1-GFP plasmid were 
grown at 30 °C in SD (+Fe) and SD with 100 µM BPS (-Fe) for 8 hours. Rtg1-GFP 
subcellular localization was determined by fluorescence microscopy. DAPI was used as 
a marker for the nucleus. A merge between GFP and DAPI is shown Representative 
images are shown (panel E). The white bar represents 10 µm. The percentage of cells 
with either predominantly cytoplasmic or nuclear GFP signal was determined by 
triplicate. The average and the standard deviation are represented (Panel F). Similar 




Gene	 expression	 studies	 on	 the	 yeast	 S.	 cerevisiae	 have	 focused	 on	 the	
alterations	 in	steady-state	mRNA	 levels	 that	occur	when	 iron	 is	scarce.	However,	
regardless	 of	 Aft1-Aft2	 mediated	 regulation,	 few	 studies	 have	 assessed	 the	
contribution	 of	 changes	 in	 the	 TR	 to	 the	 response	 to	 low	 iron	 conditions	 [34].	
Similarly	to	other	stresses	[26,	28],	iron	depletion	activates	the	yeast	ESR	program	
including	 the	 up-regulation	 of	 stress-related	 genes	 and	 the	 down-regulation	 of	
genes	implicated	in	protein	translation	(Figure	4).	The	analysis	of	both	RA	and	TR	
profiles	for	the	ESR	also	suggests	that	this	regulation	is	mainly	exerted	at	the	level	




association	 and	 translation	 of	 the	 iESR	 transcripts	 [27].	 These	 data	 strongly	
suggest	 that	 yeast	 stressed	 cells	 redirect	 its	 translational	 capacity	 toward	 the	
synthesis	of	the	induced	transcripts	[27],	which	in	the	case	of	iron	depletion	would	
presumably	 include	 the	 machinery	 for	 iron	 uptake	 and	 mobilization,	 the	 RTG	





molecular	 hazards,	 whereas	 iron	 deficiency,	 which	 is	 a	 nutritional	 defect,	 is	





RTG	via	 the	Rtg1/Rtg3	 and	Rtg2	 regulatory	 factors	 (Figure	7).	 The	physiological	
significance	of	RTG	activation	by	 iron	depletion	could	be	 to	ensure	 the	supply	of	
sufficient	α-ketoglutarate,	which	is	the	source	of	glutamate,	required	as	a	nitrogen	
donor	for	biosynthetic	processes.	This	is	especially	important	under	iron-deficient	
conditions	 because	 the	 iron-requiring	 pathway	 for	 glutamate	 synthesis	 that	
depends	on	 the	 iron	sulfur	cluster-containing	enzyme	glutamate	synthase	Glt1	 is	
repressed,	 and	 all	 glutamate	 biosynthesis	 relies	 on	 glutamate	 dehydrogenases	
Gdh1	 and	 Gdh3	 [17].	 Several	 factors	 could	 contribute	 to	 the	 initiation	 of	 the	
mitochondrial	RTG	signaling	 in	 response	 to	 iron	depletion.	 Iron	deficiency	 limits	
the	expression	of	multiple	components	of	the	TCA	cycle	and	the	electron	transport	
chain,	 which	 compromises	 mitochondrial	 respiration	 and	 eventually	 could	
decrease	 ATP	 concentration	 and	 mitochondrial	 membrane	 potential,	 which	 is	 a	
signal	 to	 activate	 the	 retrograde	 response	 [35].	 Therefore,	 mitochondrial	
malfunctions	would	be	the	main	candidate	to	trigger	RTG	activation	when	iron	is	
scarce.	However,	other	factors	could	participate	in	this	regulation.	For	instance,	the	
E3	 ubiquitin	 ligase	 complex	 SCFGrr1,	which	 positively	 regulates	 RTG	 signaling	 by	
promoting	 the	ubiquitination	and	degradation	of	 the	Rtg1/Rtg3-inhibitor	protein	
Mks1,	 has	 been	 recently	 implicated	 in	 the	 degradation	 of	 the	 iron-regulated	
protein	Cth2,	and	grr1Δ	cells	are	unable	to	grow	in	iron-deficient	conditions	[36].	
Importantly,	 the	 integral	 component	 of	 the	 TORC1	 complex	 Lst8	 negatively	
regulates	 the	 RTG	 signaling	 pathway	 acting	 both	 upstream	 and	 downstream	 of	
Rtg2	 (reviewed	 in	 [14,	 15]).	 The	 connection	 between	 the	 RTG	 and	 the	 TORC1	
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kinase	 pathway	 is	 bidirectional,	 since	mitochondrial	 dysfunctions	 also	 lead	 to	 a	
decrease	in	the	phosphorylation	state	and	activity	of	the	Sch9	kinase	[37].	
	 Studies	in	different	organisms	have	suggested	that	TOR	signaling	influences	
iron	 metabolism	 (reviewed	 in	 [38]).	 We	 showed	 that	 mammalian	 TOR	 (mTOR)	
modulates	 the	 expression	 of	 iron	 transporters	 and	 the	 cellular	 flux	 of	 iron	 via	
tristetraprolin,	 the	mammalian	Cth2	homologue	 [39].	 Consistent	with	 this,	 it	 has	
been	 shown	 that	 the	 disturbance	 of	 the	 mTORC1	 pathway	 in	 red	 blood	 cells	
resulted	 in	 anemia	 [40].	 A	 proteomic	 study	 reported	 that	 TOR	 gene	 silencing	
deregulates	 the	 import	 of	 proteins	 into	 the	mitochondria	 and	 the	 adaptation	 to	
iron	 starvation	 of	 the	 human	 pathogenic	 fungus	 Aspergillus	 fumigatus	 [41].	 In	
yeast,	the	inhibition	of	TOR	pathway	by	Torin2,	a	potent	inhibitor	of	both	TORC1	
and	 TORC2	 has	 been	 recently	 shown	 to	 increase	 the	 expression	 of	
metalloreductases	 involved	 in	 iron	uptake	 leading	 to	excess	 iron	sensitivity	 [42].	
The	influence	of	cellular	and	systemic	iron	status	on	mTOR	signaling	has	also	been	
explored	[38].	To	this	end,	the	expression	or	phosphorylation	status	of	either	the	
mTOR	 kinase,	 its	 upstream	 regulators	 Akt,	 TSC2	 or	 REDD1,	 or	 its	 downstream	
target	 ribosomal	 protein	 S6,	 have	 been	 determined.	 However,	 the	 conclusions	
drawn	with	these	studies	are	contradictory.	On	one	side,	data	with	 iron-deficient	
rats,	murine	red	blood	cells,	human	myeloid	leukemia	and	intestinal	epithelia	cells	
suggest	 that	 iron	 depletion	 could	 inactivate	mTOR	 signaling	 [40,	 43-45].	 On	 the	
other	side,	two	genetic	mouse	models	that	cause	neuronal-specific	iron	deficiency	
support	 the	 opposite	 conclusion	 [46].	 TORC1	 studies	 in	 yeast	 have	 enormously	
increased	 our	 current	 understanding	 of	 the	 contribution	 of	 this	 pathway	 to	
nutrient	 signaling	 and	 growth	 control	 [9,	 10].	 By	 using	 a	 yeast	 genome-wide	




RP,	 RiBi,	 rRNA	 and	 tRNA	 genes	 are	 consistent	with	TORC1	 inhibition	when	 iron	
bioavailability	decreases	(Figure	8).	
	
Figure 8. A model for TORC1 regulation in response to iron depletion. Upon iron 
deficiency, yeast cells inhibit the TORC1 pathway. Consequently, yeast represses the 
transcription of RP and RiBi genes, and the activity of the RNA Pol I and III. Moreover, 
the ESR pathway is transcriptionally activated in response to iron scarcity. Multiple 
effectors of the TORC1 pathway including the Sch9 kinase, Maf1, Rps6 and the 
transcription factors Sfp1, Dot6 and Msn2/Msn4 are regulated by iron bioavailability. 
	
	 TORC1	 constitutes	 a	 major	 hub	 to	 sense	 and	 respond	 to	 nutrients,	 in	
























systemic	 iron	 homeostasis	 is	 on	 the	 basis	 of	 microbial	 pathogenesis	 and	 many	
disorders	 including	 chronic	 anemia,	 hemochromatosis,	 thalassemia,	
aceruloplasminemia,	 various	 neurodegenerative	 diseases	 and	 cancer	 [47];	
whereas	 TORC1	 has	 been	 implicated	 in	 fungal	 virulence,	 aging,	 cancer,	
cardiovascular	 diseases,	 and	 autoimmune	 and	 metabolic	 disorders	 such	 as	
diabetes	and	obesity	[9,	11,	48].	A	better	comprehension	of	the	crosstalk	between	
eukaryotic	iron	metabolism,	TOR	signaling	and	microbial	virulence	is	necessary	to	
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of	 iron	 starvation.	 (D)	 Cell	 volume	 was	 determined	 during	 the	 growth	 in	 iron-
deficient	conditions	as	described	 in	Materials	and	Methods.	 (E)	 Intracellular	 iron	
levels	of	W303	cells	at	time	zero,	and	after	30	and	180	minutes	of	iron	depletion.	











used	 to	 normalize.	 Mean	 values	 and	 standard	 deviations	 from	 at	 least	 two	
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levels.	 Yeast	 cells	 expressing	 DOT6-HA	 were	 grown	 as	 in	 Figure	 5G,	 and	 in	 the	
presence	 of	 rapamycin	 (200	 ng/mL)	 for	 30	minutes.	 Dot6-HA	 and	 Pgk1	 protein	
levels	 were	 quantified	 and	 the	 Dot6-HA/Pgk1	 ratio	 indicated.	 (D)	 Sch9	 protein	
levels.	 	Yeast	cells	expressing	SCH9-HA	were	cultivated	as	described	in	Figure	5H.	
Total	 proteins	 were	 extracted	 and	 Sch9-HA	 and	 Pgk1	 protein	 levels	 were	
determined	 by	 Western	 blot.	 The	 Sch9/Pgk1	 ratio	 is	 shown.	 (E)	 Sch9	







Figure	 S3.	Rrp12	 localizes	 to	 the	nucleus	 in	 iron-deficient	 conditions.	Yeast	
cells	expressing	RRP12-GFP	were	grown	in	SC	(+Fe)	and	SC	with	100	µM	de	BPS	(-











Figure	 S4.	 Maf1	 is	 dephosphorylated	 during	 the	 iron	 deficiency	 progress.	
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standard	 deviations	 from	 at	 least	 two	 independent	 experiments	 are	 shown.	 (B)	
Wild	 type	BY4741,	 rtg1Δ,	 rtg2Δ	 and	 rtg3Δ	 strains	 transformed	with	 the	 plasmid	
PACO1-lacZ	were	grown	at	30	°C	in	SC-ura	(+Fe)	and	SC-ura	with	100	µM	BPS	(-Fe)	
for	9	hours.	β-Galactosidase	assays	were	carried	out	as	described	in	Materials	and	
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